Tim Maughan
Professor of Clinical Oncology
- Clinical Director of the Oxford Institute for Radiation Oncology
Research Summary
We aim to deliver a step change in the effectiveness of radiotherapy through the evaluation of novel scientific approaches derived from the Institute's scientists in hypothesis driven clinical trials.
Biography
Tim Maughan was appointed Professor of Clinical Oncology and Clinical Director of the Oxford Institute for Radiation Oncology in the Department of Oncology in 2011. Previously, Tim worked as an NHS consultant Clinical Oncologist in Cardiff, becoming Professor of Cancer Studies in 2007. During that time, he established the first clinical research network, the Wales Cancer Trials Network, and subsequently the development of the clinical research networks across the UK.
He was the founding chair of the NCRI Clinical and Translational Radiotherapy Research Working Group (CTRad), which has a broad remit to enhance radiotherapy research in the UK.
GROUP MEMBERS
Recent publications
-
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer.
Journal article
Malla SB. et al, (2021), Clin Cancer Res, 27, 288 - 300
-
A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment.
Journal article
Viratham Pulsawatdi A. et al, (2020), Mol Oncol
-
Fusobacterium nucleatum, rectal cancer and radiotherapy.
Journal article
Mann EH. and Maughan TS., (2020), Ann Oncol
-
Image-based consensus molecular subtype classification (imCMS) of colorectal cancer using deep learning
Journal article
VERRILL C. et al, (2020), Gut
-
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol.
Journal article
Brown NF. et al, (2020), BMC Cancer, 20